Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation regimens for patients undergoing transesophageal echocardiography
IRCT20200825048515N82Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midazolam, propofol, ketamine and fentanyl in anxiety disorder (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Sedation quality. Started Jul 2025; status: completed.
02
Drugs
midazolampropofolketaminefentanyl
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20200825048515N82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N82.